Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Gravitational collapse of Mount Etna's southeastern flank.

Urlaub M, Petersen F, Gross F, Bonforte A, Puglisi G, Guglielmino F, Krastel S, Lange D, Kopp H.

Sci Adv. 2018 Oct 10;4(10):eaat9700. doi: 10.1126/sciadv.aat9700. eCollection 2018 Oct.

2.

CT-response patterns and the role of CT-textural features in inoperable abdominal/retroperitoneal soft tissue sarcomas treated with trabectedin.

Esser M, Kloth C, Thaiss WM, Reinert CP, Fritz J, Kopp HG, Horger M.

Eur J Radiol. 2018 Oct;107:175-182. doi: 10.1016/j.ejrad.2018.09.006. Epub 2018 Sep 6.

PMID:
30292263
3.

Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group.

Fenner M, Oing C, Dieing A, Gauler T, Oechsle K, Lorch A, Hentrich M, Kopp HG, Bokemeyer C, Honecker F.

J Cancer Res Clin Oncol. 2018 Sep 19. doi: 10.1007/s00432-018-2752-z. [Epub ahead of print]

PMID:
30232558
4.

LBA-008Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, randomized phase 3 FLOT4 trial (German Gastric Group at AIO).

Al-Batran SE, Pauligk C, Homann N, Schmalenberg H, Kopp HG, Haag GM, Luley Kim B, Schmiegel Wolff H, Folprecht G, Probst S, Prasnikar N, Thuss-Patience Peter C, Trojan J, Goetze TO, Meiler J, Schuler Martin H, Jäger E, Hofheinz RD.

Ann Oncol. 2017 Jun 1;28(suppl_3). doi: 10.1093/annonc/mdx302.007. No abstract available.

PMID:
30052790
5.

Long-term remission of refractory Rosai-Dorfman disease after salvage therapy with clofarabine in an adult patient.

Hinterleitner C, Steurer M, Dörfel D, Heitmann J, Kreisselmeier KP, Müller K, Kopp HG, Wirths S, Haap M, de Fend LQ, Horger M, Rodriguez-Galindo C, Kanz L, Müller MR.

Ann Hematol. 2018 Jul 6. doi: 10.1007/s00277-018-3421-7. [Epub ahead of print] No abstract available.

PMID:
29980874
6.

Impact of surgery in patients with metastatic soft tissue sarcoma: A monocentric retrospective analysis.

Wigge S, Heißner K, Steger V, Ladurner R, Traub F, Sipos B, Bösmüller H, Kanz L, Mayer F, Kopp HG.

J Surg Oncol. 2018 Jul;118(1):167-176. doi: 10.1002/jso.25115. Epub 2018 Jun 28.

PMID:
29953623
7.

Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation.

Löffler MW, Kowalewski DJ, Backert L, Bernhardt J, Adam P, Schuster H, Dengler F, Backes D, Kopp HG, Beckert S, Wagner S, Königsrainer I, Kohlbacher O, Kanz L, Königsrainer A, Rammensee HG, Stevanović S, Haen SP.

Cancer Res. 2018 Aug 15;78(16):4627-4641. doi: 10.1158/0008-5472.CAN-17-1745. Epub 2018 May 22.

PMID:
29789417
8.

The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphoma.

Kropp KN, Maurer S, Rothfelder K, Schmied BJ, Clar KL, Schmidt M, Strunz B, Kopp HG, Steinle A, Grünebach F, Rittig SM, Salih HR, Dörfel D.

Cancer Immunol Immunother. 2018 Jun;67(6):935-947. doi: 10.1007/s00262-018-2151-y. Epub 2018 Mar 19.

PMID:
29556699
9.

The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells.

Dörfel D, Lechner CJ, Joas S, Funk T, Gutknecht M, Salih J, Geiger J, Kropp KN, Maurer S, Müller MR, Kopp HG, Salih HR, Grünebach F, Rittig SM.

Cancer Immunol Immunother. 2018 May;67(5):775-783. doi: 10.1007/s00262-018-2129-9. Epub 2018 Feb 21.

PMID:
29468363
10.

Low plasma protein Z levels are associated with an increased risk for perioperative bleedings.

Hinterleitner C, Kreisselmeier KP, Pecher AC, Mauz PS, Kanz L, Kopp HG, Jaschonek KG.

Eur J Haematol. 2018 May;100(5):403-411. doi: 10.1111/ejh.13031. Epub 2018 Mar 26.

PMID:
29360177
11.

Integrative genomic and transcriptomic analysis of leiomyosarcoma.

Chudasama P, Mughal SS, Sanders MA, Hübschmann D, Chung I, Deeg KI, Wong SH, Rabe S, Hlevnjak M, Zapatka M, Ernst A, Kleinheinz K, Schlesner M, Sieverling L, Klink B, Schröck E, Hoogenboezem RM, Kasper B, Heilig CE, Egerer G, Wolf S, von Kalle C, Eils R, Stenzinger A, Weichert W, Glimm H, Gröschel S, Kopp HG, Omlor G, Lehner B, Bauer S, Schimmack S, Ulrich A, Mechtersheimer G, Rippe K, Brors B, Hutter B, Renner M, Hohenberger P, Scholl C, Fröhling S.

Nat Commun. 2018 Jan 10;9(1):144. doi: 10.1038/s41467-017-02602-0.

12.

Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells.

Maurer S, Kropp KN, Klein G, Steinle A, Haen SP, Walz JS, Hinterleitner C, Märklin M, Kopp HG, Salih HR.

Oncoimmunology. 2017 Nov 27;7(2):e1364827. doi: 10.1080/2162402X.2017.1364827. eCollection 2018.

PMID:
29308299
13.

NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia.

Märklin M, Heitmann JS, Fuchs AR, Truckenmüller FM, Gutknecht M, Bugl S, Saur SJ, Lazarus J, Kohlhofer U, Quintanilla-Martinez L, Rammensee HG, Salih HR, Kopp HG, Haap M, Kirschniak A, Kanz L, Rao A, Wirths S, Müller MR.

Nat Commun. 2017 Oct 2;8(1):755. doi: 10.1038/s41467-017-00830-y.

14.

Prevalence of Micronutrient Deficiency in Patients with Morbid Obesity Before Bariatric Surgery.

Krzizek EC, Brix JM, Herz CT, Kopp HP, Schernthaner GH, Schernthaner G, Ludvik B.

Obes Surg. 2018 Mar;28(3):643-648. doi: 10.1007/s11695-017-2902-4.

PMID:
28849358
15.

Radiotherapy and hyperthermia with curative intent in recurrent high risk soft tissue sarcomas.

Eckert F, Braun LH, Traub F, Kopp HG, Sipos B, Lamprecht U, Müller AC, Paulsen F, Zips D.

Int J Hyperthermia. 2018 Nov;34(7):980-987. doi: 10.1080/02656736.2017.1369174. Epub 2017 Sep 5.

PMID:
28826283
16.

Dehydration of subducting slow-spread oceanic lithosphere in the Lesser Antilles.

Paulatto M, Laigle M, Galve A, Charvis P, Sapin M, Bayrakci G, Evain M, Kopp H.

Nat Commun. 2017 Jul 10;8:15980. doi: 10.1038/ncomms15980.

17.

A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors.

Wagner AJ, Kindler H, Gelderblom H, Schöffski P, Bauer S, Hohenberger P, Kopp HG, Lopez-Martin JA, Peeters M, Reichardt P, Qin A, Nippgen J, Ilaria RL, Rutkowski P.

Ann Oncol. 2017 Mar 1;28(3):541-546. doi: 10.1093/annonc/mdw659.

18.

[Imaging of Metastastic Renal Cell Carcinoma under Therapy with Immune Checkpoint Inhibitors].

Notohamiprodjo M, Kopp HG, Bedke J.

Rofo. 2017 Apr;189(4):287-292. doi: 10.1055/s-0043-100511. Epub 2017 Mar 23. Review. German. No abstract available.

PMID:
28335045
19.

PS01.60: Ph Ib/II, Trial of INC280 ± Erlotinib vs Platinum + Pemetrexed in Adult pts with EGFR-Mutated, cMET amplified, EGFR TKI Resistant, Advanced NSCLC: Topic: Medical Oncology.

Rybkin II, Smit E, Kopp HG, Kim DW, Spira A, Berruti A, Lee DH, Reguart N, Akimov M, Schumacher K, Upalawanna A, Squires M, Tan DS.

J Thorac Oncol. 2016 Nov;11(11S):S307-S308. doi: 10.1016/j.jtho.2016.09.095. Epub 2016 Oct 28. No abstract available.

20.

Targeted Treatment of Esophagogastric Cancer.

Kopp HG, Hofheinz RD.

Oncol Res Treat. 2016;39(12):788-794. Epub 2016 Nov 22. Review.

21.

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.

Al-Batran SE, Hofheinz RD, Pauligk C, Kopp HG, Haag GM, Luley KB, Meiler J, Homann N, Lorenzen S, Schmalenberg H, Probst S, Koenigsmann M, Egger M, Prasnikar N, Caca K, Trojan J, Martens UM, Block A, Fischbach W, Mahlberg R, Clemens M, Illerhaus G, Zirlik K, Behringer DM, Schmiegel W, Pohl M, Heike M, Ronellenfitsch U, Schuler M, Bechstein WO, Königsrainer A, Gaiser T, Schirmacher P, Hozaeel W, Reichart A, Goetze TO, Sievert M, Jäger E, Mönig S, Tannapfel A.

Lancet Oncol. 2016 Dec;17(12):1697-1708. doi: 10.1016/S1470-2045(16)30531-9. Epub 2016 Oct 22.

PMID:
27776843
22.

Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patients.

Schuler MK, Gerdes S, West A, Richter S, Busemann C, Hentschel L, Lenz F, Kopp HG, Ehninger G, Reichardt P, Pink D.

BMC Cancer. 2016 Aug 9;16:619. doi: 10.1186/s12885-016-2654-x.

23.

Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).

Joerger M, von Pawel J, Kraff S, Fischer JR, Eberhardt W, Gauler TC, Mueller L, Reinmuth N, Reck M, Kimmich M, Mayer F, Kopp HG, Behringer DM, Ko YD, Hilger RA, Roessler M, Kloft C, Henrich A, Moritz B, Miller MC, Salamone SJ, Jaehde U.

Ann Oncol. 2016 Oct;27(10):1895-902. doi: 10.1093/annonc/mdw290. Epub 2016 Aug 8.

PMID:
27502710
24.

Liposarcoma of the Spermatic Cord: Impact of Final Surgical Intervention--An Institutional Experience.

Bachmann R, Rolinger J, Girotti P, Kopp HG, Heissner K, Amend B, Königsrainer A, Ladurner R.

Int J Surg Oncol. 2016;2016:4785394. doi: 10.1155/2016/4785394. Epub 2016 Apr 14.

25.

Enhanced eryptosis contributes to anemia in lung cancer patients.

Bissinger R, Schumacher C, Qadri SM, Honisch S, Malik A, Götz F, Kopp HG, Lang F.

Oncotarget. 2016 Mar 22;7(12):14002-14. doi: 10.18632/oncotarget.7286.

26.

Choroidal metastases from thymic carcinoma during pregnancy: Case Report.

Haen SP, Stroebel P, Marx A, Suesskind D, Fend F, Reichmann U, Kopp HG, Kanz L, Mayer F.

BMC Cancer. 2015 Dec 16;15:972. doi: 10.1186/s12885-015-1968-4.

27.

Post abortion contraception.

Gemzell-Danielsson K, Kopp HK.

Womens Health (Lond). 2015 Nov;11(6):779-84. doi: 10.2217/whe.15.72. Epub 2015 Nov 30.

PMID:
26619082
28.

[Pulmonary infection in neutropenia].

Haap M, Neumayer B, Kopp HG, Peter S, Haen S, Riessen R, Artunc F, Fend F, Kanz L, Müller MR.

Dtsch Med Wochenschr. 2015 Mar;140(6):426-7. doi: 10.1055/s-0041-100947. Epub 2015 Mar 16. German.

PMID:
25774734
29.

Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT.

Homann G, Mustafa DF, Ditt H, Spengler W, Kopp HG, Nikolaou K, Horger M.

Acad Radiol. 2015 Apr;22(4):505-12. doi: 10.1016/j.acra.2014.12.005. Epub 2015 Jan 10.

PMID:
25586709
30.

Paraneoplastic granulocyte colony-stimulating factor secretion in soft tissue sarcoma mimicking myeloproliferative neoplasia: a case report.

Dorn C, Bugl S, Malenke E, Müller MR, Weisel KC, Vogel U, Horger M, Kanz L, Kopp HG.

BMC Res Notes. 2014 May 23;7:313. doi: 10.1186/1756-0500-7-313.

31.

Neutrophil homeostasis and its regulation by danger signaling.

Wirths S, Bugl S, Kopp HG.

Blood. 2014 Jun 5;123(23):3563-6. doi: 10.1182/blood-2013-11-516260. Epub 2014 Apr 28.

32.

First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG).

Berger LA, Bokemeyer C, Lorch A, Hentrich M, Kopp HG, Gauler TC, Beyer J, de Wit M, Mayer F, Boehlke I, Oing C, Honecker F, Oechsle K.

J Cancer Res Clin Oncol. 2014 Jul;140(7):1211-20. doi: 10.1007/s00432-014-1661-z. Epub 2014 Apr 3.

PMID:
24696231
33.

[End-stage renal disease after sarcoma therapy - case 3/2014].

Baumann D, Amann K, Schlatter E, Ciarimboli G, Kopp HG, Müller M, Kluba T, Bakos G, Steinke I, Bunz H, Weyrich P, Artunc F.

Dtsch Med Wochenschr. 2014 Apr;139(15):785. doi: 10.1055/s-0033-1360084. Epub 2014 Apr 1. German.

34.

[Peripheral artery disease as supplemental diagnosis in coronary heart disease--influence on diagnostics, treatment and prognosis].

Espinola-Klein C, Savvidis S, Kopp H.

Dtsch Med Wochenschr. 2014 Jan;139 Suppl 1:S40-2. doi: 10.1055/s-0033-1359958. Epub 2014 Jan 20. Review. German.

PMID:
24446044
35.

[Gastrointestinal stromal tumours bigger than 20 cm: experience with imatinib chemotherapy in neoadjuvant intention].

Girotti P, Rolinger J, Kopp HG, Königsrainer A, Ladurner R.

Z Gastroenterol. 2014 Jan;52(1):50-4. doi: 10.1055/s-0033-1356371. Epub 2014 Jan 13. German.

PMID:
24420799
36.

Management of disseminated intravascular coagulopathy with direct factor Xa inhibitor rivaroxaban in Klippel-Trénaunay syndrome.

Randrianarisoa E, Kopp HG, Balletshofer BM, Jaschonek K, Kanz L, Haering HU, Rittig K.

Blood Coagul Fibrinolysis. 2013 Oct;24(7):766-70. doi: 10.1097/MBC.0b013e3283626238.

PMID:
24030117
37.

[Advantages of volume perfusion CT for evaluating the response of solid tumors to treatment with sunitinib].

Horger M, Wiesinger B, Kopp HG, Ioanoviciu SD, Bitzer M, Spira D, Schulze M.

Rofo. 2013 Jul;185(7):595-602. doi: 10.1055/s-0032-1319576. Epub 2013 Jun 26. German. No abstract available.

PMID:
23804124
38.

The benefit of using CT-perfusion imaging for reliable response monitoring in patients with gastrointestinal stromal tumor (GIST) undergoing treatment with novel targeted agents.

Betz M, Kopp HG, Spira D, Claussen CD, Horger M.

Acta Radiol. 2013 Sep;54(7):711-21. doi: 10.1177/0284185113484642. Epub 2013 May 12. Review.

PMID:
23761542
39.

[Unusual cause of macrohematuria in a 29-year-old woman].

Saur SJ, Häntschel M, Artunc F, Rittig SM, Janssen U, Kanz L, Jaschonek K, Vogel W, Kopp HG.

Dtsch Med Wochenschr. 2013 Apr;138(16):Seite 1-30. doi: 10.1055/s-0032-1332933. Epub 2013 Apr 22. German.

PMID:
23608886
40.

Effect of concurrent chemotherapy and hyperthermia on outcome of preoperative radiotherapy of high-risk soft tissue sarcomas.

Eckert F, Gani C, Kluba T, Mayer F, Kopp HG, Zips D, Bamberg M, Müller AC.

Strahlenther Onkol. 2013 Jun;189(6):482-5. doi: 10.1007/s00066-013-0312-7. Epub 2013 Apr 21.

PMID:
23604183
41.

Progesterone and estrogen prevent cisplatin-induced apoptosis of lung cancer cells.

Grott M, Karakaya S, Mayer F, Baertling F, Beyer C, Kipp M, Kopp HG.

Anticancer Res. 2013 Mar;33(3):791-800.

PMID:
23482746
42.

Steady-state neutrophil homeostasis is a demand-driven process.

Wirths S, Bugl S, Kopp HG.

Cell Cycle. 2013 Mar 1;12(5):709-10. doi: 10.4161/cc.23859. Epub 2013 Feb 19. No abstract available.

43.

Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis.

Berchtold S, Lampe J, Weiland T, Smirnow I, Schleicher S, Handgretinger R, Kopp HG, Reiser J, Stubenrauch F, Mayer N, Malek NP, Bitzer M, Lauer UM.

J Virol. 2013 Mar;87(6):3484-501. doi: 10.1128/JVI.02106-12. Epub 2013 Jan 9.

44.

Shared cell surface marker expression in mesenchymal stem cells and adult sarcomas.

Wirths S, Malenke E, Kluba T, Rieger S, Müller MR, Schleicher S, Hann von Weyhern C, Nagl F, Fend F, Vogel W, Mayer F, Kanz L, Bühring HJ, Kopp HG.

Stem Cells Transl Med. 2013 Jan;2(1):53-60. doi: 10.5966/sctm.2012-0055. Epub 2012 Dec 19.

45.

Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling.

Bugl S, Wirths S, Radsak MP, Schild H, Stein P, André MC, Müller MR, Malenke E, Wiesner T, Märklin M, Frick JS, Handgretinger R, Rammensee HG, Kanz L, Kopp HG.

Blood. 2013 Jan 31;121(5):723-33. doi: 10.1182/blood-2012-05-429589. Epub 2012 Dec 5.

46.

RANKL expression, function, and therapeutic targeting in multiple myeloma and chronic lymphocytic leukemia.

Schmiedel BJ, Scheible CA, Nuebling T, Kopp HG, Wirths S, Azuma M, Schneider P, Jung G, Grosse-Hovest L, Salih HR.

Cancer Res. 2013 Jan 15;73(2):683-94. doi: 10.1158/0008-5472.CAN-12-2280. Epub 2012 Nov 8.

47.

Current insights into neutrophil homeostasis.

Bugl S, Wirths S, Müller MR, Radsak MP, Kopp HG.

Ann N Y Acad Sci. 2012 Aug;1266:171-8. doi: 10.1111/j.1749-6632.2012.06607.x. Review.

PMID:
22901268
48.

[Severe hemorrhage in a patient with metastatic colorectal cancer - case 8/2012].

Orgel M, Horger M, Kurth R, Kanz L, Jaschonek K, Mayer F, Kopp HG.

Dtsch Med Wochenschr. 2012 Aug;137(34-35):1705. doi: 10.1055/s-0032-1305227. Epub 2012 Aug 14. German.

PMID:
22893052
49.

The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity.

Brix JM, Höllerl F, Kopp HP, Schernthaner GH, Schernthaner G.

Int J Obes (Lond). 2012 Nov;36(11):1412-7. doi: 10.1038/ijo.2012.107. Epub 2012 Jul 17.

PMID:
22828946
50.

Pemetrexed in patients with refractory soft tissue sarcoma: a non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005.

Hartmann JT, Bauer S, Egerer G, Horger MS, Kopp HG, Grünwald V, Mayer F.

Invest New Drugs. 2013 Feb;31(1):167-74. doi: 10.1007/s10637-012-9840-8. Epub 2012 Jul 5.

PMID:
22763609

Supplemental Content

Support Center